Seventh Time A Charm
‘Get right and sit tight’ … Livermore
Well, it’s the ‘get right’ part that’s the challenge.
As for Biotech SPBIO, it’s no secret it’s been on again, off again, then back on again.
So, it is. Based on current price acton, yesterday was a head-fake into the 38% retrace.
This morning’s session attempted to move higher but was rejected within the first 3-minutes.
Once again, the short trade via LABD, has been re-established (not advice, not a recommendation).
We have LABD-22-07; entered at 21.88, with a stop at the session low of 20.88.
At this juncture (10:50 a.m., EST), Inverse Fund LABD, is pushing higher.
The hourly chart of SPBIO, shows the 38% retrace and reversal.
Biotech SPBIO, Hourly
As of this post (10:50 a.m., EST) price action has just filled the gap from yesterday’s session. Some amount of SPBIO, retrace higher (below this morning’s highs) is reasonable.
The groundwork has already been laid over the past few months and even as far back as one year, why this sector may be set for a stupendous decline.
Of course, we don’t know if ‘this is it’, until it’s all over.
For now, the LABD position is in the green with a hard stop at the session low of 20.88 (not advice, not a recommendation).
Charts by StockCharts
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point®, trade mark: No. 6,505,279